期刊文献+

生理钙腹膜透析液对钙磷代谢达标及血管钙化影响的研究 被引量:5

Effects of physiological calcium peritoneal dialysis on the disorders of serum calcium and phosphorus metabolism and vascular calcification
下载PDF
导出
摘要 目的:探讨生理钙腹膜透析对患者钙磷代谢紊乱和心血管钙化的影响。方法:2009年1月至2015年6月在我院规律随访大于12个月的134例腹膜透析患者,根据使用透析液钙离子浓度不同分为高钙透析组、生理钙透析组。比较患者治疗12个月前后的钙磷代谢情况、心脏超声及血管钙化等相关指标。结果:71例高钙透析组患者在治疗12个月后,其血钙水平显著高于使用生理钙透析组的58例患者(P<0.01)。高钙透析组患者在治疗12个月后,其血钙、冠脉积分、腹主动脉积分水平较基线水平升高程度显著高于生理钙透析组患者(P<0.05)。5例患者随访中由高钙透析液转为生理钙透析液,在更换为生理钙透析液治疗12个月后,患者血钙显著降低、iPTH明显升高(P<0.05)。与高钙透析组患者比较,生理钙透析组和高钙转生理钙透析组患者在治疗12个月后,活性维生素D的使用和血钙达标的比例显著高于前者(P<0.05)。高钙转生理钙透析液的5例患者在改用生理钙透析液后患者的iPTH达标率显著增加(P<0.05)。结论:与高钙透析液相比,使用生理钙透析液有利于维持腹膜透析患者血钙的达标,改善iPTH代谢,并延缓血管钙化的进程。 Objective: To investigate the calcium-phosphorus metabolism and cardiovascular system in patients using physiological calcium peritoneal dialysis fluid. Methods: A total of 134 peritoneal dialysis patients who had been followed-up for more than 12 months were divided into high calcium dialysis group and physiological calcium dialysis group according to the types of dialysate they used. After 12 months of treatment,the general situation,serum levels of calcium and phosphorus and the indices of cardiac ultrasound and vascular calcification were compared between the two groups. Results: After 12 months of treatment,the serum calcium level was significantly increased in high calcium dialysis group( P < 0. 01). The increments of serum calcium,calcification scores of coronary arteries and abdominal aorta were more prominent in the high calcium dialysis group than those in the physiological calcium dialysis group( P < 0. 05). For the 5 patients who had changed their dialysate from high calcium to physical calcium,the 12-month treatment of physical calcium dialysate made their serum calcium significantly decreased and the iPTH level markedly increased( P < 0. 05). As compared with the patients in high calcium group,those in physical calcium group and the five patients who had switched to physical calcium dialysate had a higher proportions of vitamin D administration and a more ideal serum calcium level. After patients replaced their dialysis therapy from high calcium dialysate to physical calcium dialysate,the standard-reaching rate of serum iPTH and calcium increased. Conclusions: Physical calcium dialysate are helpful for the patients to maintain ideal serum calcium and improve iPTH variation,and delay the aggregation of vascular calcification.
出处 《东南大学学报(医学版)》 CAS 北大核心 2017年第6期1009-1014,共6页 Journal of Southeast University(Medical Science Edition)
关键词 腹膜透析 生理钙 钙磷代谢 血管钙化 peritoneal dialysis physiological calcium calcium and phosphorus metabolism vascular calcification
  • 相关文献

参考文献3

二级参考文献25

  • 1孙鲁英,左力,王梅.不同钙离子浓度透析液对血液透析患者钙平衡及甲状旁腺素的影响[J].中华肾脏病杂志,2004,20(3):210-213. 被引量:51
  • 2陈育青,王梅.低钙透析液对血甲状旁腺素及钙磷代谢的影响[J].肾脏病与透析肾移植杂志,2005,14(1):34-36. 被引量:30
  • 3Young EW,Albert JM,Satayathum S,et al.Predictors and consequences of altered mineral metabolism:The Dialysis Outcomes and Practice Patterns Study.Kidney Int,2005,67:1179-1187.
  • 4Locatelli F.The need for better control of secondary parathyroidism.Nephrol Dial Trans,2005,19 Suppl 5 :v15-v19.
  • 5Weinreich T,Ritz E,Passlick-Deetjen J.Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD:effects on bone mineral metabolism.Collaborators of the Multicenter Study Group.Perit Dial Int,1996,16:260-268.
  • 6Brandi L,Melsen PK,Bro S,et al.Long-term effects of intermittent oral alphacalcidol,calcium carbonate and lowcalcium dialysis ( 1.25mmol/L) on secondary hyperparathyroidism in patients on CAPD.J Inter Med,1998,244:121-131.
  • 7Amstrong A,Beer J,Noonan K,et al.Reduced calcium dialysate in CAPD patients:efficacy and limitations.Nephrol Dial Transplant,1997,12:1223-1228.
  • 8Bro S,Brandi L,Daugaard H,et al.Calcium concentration in the CAPD dialysate:what is optimal and is there a need to individualize? Perit Dial lnt,1997,17:554-559.
  • 9Sanchez C,L6pez-Barea F,Sánchez-Cabezudo J,et al.Low vs standard calcium dialysate in peritoneal dialysis:differences in treatment,biochemistry and bone histomorphometry.A randomized multicentre study.Nephrol Dial Trans,2004,19:1587-1593.
  • 10Eknoyan G,Levin A,Levin NW,et al.Bone metabolism and disease in chronic kidney disease.Am J Kidney Dis,2003,42 Suppl 3 :S7-S201.

共引文献32

同被引文献41

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部